84,426 Shares in Avantor, Inc. (NYSE:AVTR) Purchased by Rialto Wealth Management LLC

Rialto Wealth Management LLC acquired a new stake in shares of Avantor, Inc. (NYSE:AVTR) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 84,426 shares of the company’s stock, valued at approximately $1,779,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. State Street Corp boosted its stake in shares of Avantor by 58.0% during the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock valued at $578,666,000 after buying an additional 8,206,695 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in Avantor by 653.0% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock valued at $159,740,000 after acquiring an additional 5,354,678 shares during the last quarter. FMR LLC grew its holdings in Avantor by 557.2% during the 3rd quarter. FMR LLC now owns 4,675,283 shares of the company’s stock worth $120,950,000 after acquiring an additional 3,963,912 shares in the last quarter. Janus Henderson Group PLC grew its holdings in Avantor by 18.2% during the 3rd quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock worth $457,710,000 after acquiring an additional 2,719,615 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Avantor in the 4th quarter worth about $33,091,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Avantor

In other Avantor news, EVP James Bramwell sold 3,758 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the transaction, the executive vice president now owns 87,379 shares of the company’s stock, valued at approximately $1,531,753.87. This trade represents a 4.12 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $86,019.71. Following the sale, the chief accounting officer now owns 40,604 shares in the company, valued at $711,788.12. This trade represents a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.30% of the company’s stock.

Avantor Stock Performance

Shares of AVTR opened at $17.54 on Friday. The firm has a fifty day moving average of $19.99 and a 200-day moving average of $22.37. The company has a market cap of $11.94 billion, a price-to-earnings ratio of 16.86, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. Avantor, Inc. has a 1 year low of $15.37 and a 1 year high of $28.00.

Avantor (NYSE:AVTR) last posted its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter last year, the business posted $0.22 earnings per share. As a group, equities analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Stifel Nicolaus reduced their price target on shares of Avantor from $28.00 to $26.00 and set a “buy” rating on the stock in a research report on Monday, February 10th. Citigroup reduced their target price on Avantor from $22.00 to $18.00 and set a “neutral” rating on the stock in a report on Tuesday. UBS Group reiterated a “neutral” rating and issued a $25.00 price target (down from $29.00) on shares of Avantor in a report on Friday, January 17th. Morgan Stanley reduced their price objective on Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Monday, February 10th. Finally, Raymond James reiterated an “outperform” rating and set a $24.00 target price (down previously from $26.00) on shares of Avantor in a research note on Monday, February 10th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $25.50.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.